Basic and clinical pharmacology of new motility promoting agents.
about
Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the LiteratureRETRACTED: Interventions That Affect Gastrointestinal Motility in Hospitalized Adult Patients: A Systematic Review and Meta-Analysis of Double-Blind Placebo-Controlled Randomized TrialsTreatment of opioid-induced gut dysfunctionFunctional GI disorders: from animal models to drug development.A case report on a patient suffering from recurrent vomiting episodes, whose condition improved markedly during pregnancy and breast feedingVgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.Oxytocin prolongs the gastric emptying time in patients with diabetes mellitus and gastroparesis, but does not affect satiety or volume intake in patients with functional dyspepsia.The role of experimental models in developing new treatments for irritable bowel syndrome.New insights into the understanding of gastrointestinal dysmotilityAnesthetic Routines: The Anesthesiologist's Role in GI Recovery and Postoperative IleusCost-effectiveness of prucalopride in the treatment of chronic constipation in the NetherlandsInhibitory effect of Suaeda asparagoides (Miq.) extract on the motility of rat gastric antrum is mediated by β-adrenoceptor.Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids.Irregular gastrointestinal drug absorption in Parkinson's disease.Synchronized gastric electrical stimulation improves vagotomy-induced impairment in gastric accommodation via the nitrergic pathway in dogsEffects of Lizhong Tang on gastrointestinal motility in mice.Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.Median arcuate ligament syndrome in the pediatric population.Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.A review of mixing and propulsion of chyme in the small intestine: fresh insights from new methods.Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway.5-HT4 receptor activation facilitates recovery from synaptic rundown and increases transmitter release from single varicosities of myenteric neurons.Electrogastrography in adults and children: the strength, pitfalls, and clinical significance of the cutaneous recording of the gastric electrical activity.Mechanisms underlying feed intolerance in the critically ill: implications for treatment.Effect of DA-9701 on gastric emptying in a mouse model: assessment by ¹³C-octanoic acid breath test.Ameliorating effects and mechanisms of electroacupuncture on gastric dysrhythmia, delayed emptying, and impaired accommodation in diabetic rats.Standardized treatment of Chinese medicine decoction for cancer pain patients with opioid-induced constipation: a multi-center prospective randomized controlled study.5-HT4 receptors facilitate cholinergic neurotransmission throughout the murine gastrointestinal tract.Experimental pancreatitis disturbs gastrointestinal and colonic motility in mice: effect of the prokinetic agent tegaserod.Characterization of Enterococcus Isolates Colonizing the Intestinal Tract of Intensive Care Unit Patients Receiving Selective Digestive Decontamination.Spatiotemporal organization of standing postprandial contractions in the distal ileum of the anesthetized pig.Prokinetic effects of a new 5-HT4 agonist, YKP10811, on gastric motility in dogs.Synergy between 5-HT4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle.Real-time measurement of serotonin release and motility in guinea pig ileum.cAMP Catalyzing Phosphodiesterases Control Cholinergic Muscular Activity But Their Inhibition Does Not Enhance 5-HT4 Receptor-Mediated Facilitation of Cholinergic Contractions in the Murine Gastrointestinal Tract.Treatment of poststroke constipation with moxibustion: A case report.Meranzin Hydrate Induces Similar Effect to Fructus Aurantii on Intestinal Motility through Activation of H1 Histamine ReceptorsGastroprotective and gastric motility benefits of AD-lico/Healthy Gut™ Glycyrrhiza inflata extract
P2860
Q26747576-B361C01F-89A7-47A2-812C-B8955F70FDE3Q26769038-7F26105C-7D1F-4690-8C1B-3FC557598225Q28284578-9CEE6971-5C90-470C-A7CF-9DFA9EE0590FQ30433078-CEA7578B-567D-47B5-ABBE-085D40D17C39Q33261036-3ED2CB25-E7EA-4319-BC13-D76FD6D6042DQ33296232-56504CD6-7BE6-4D5F-9EB8-C4C60DB1D251Q34197096-614FD6B6-B495-4F3E-BFA3-E6D484FF0AAAQ35071310-B57BB62A-832C-4C69-BE74-F0308022A98FQ35161786-2C42C0F7-FEF9-4BB4-9997-2C9F7CEB74BBQ35202119-BD010791-F632-440C-9640-7A425896D025Q35407243-00A33A96-2B3F-4348-A00B-26AB161ED7DEQ35653404-15F9CDF4-B9ED-4596-81ED-ACB82E4E84EFQ36751995-240A1186-1FE2-48E2-A3DA-5D1550FFD22EQ37076343-E99AF927-BFC1-4016-A208-A6731B2E759AQ37100273-873DFEA0-F83C-4B13-B932-2ADAAB64CCDFQ37242785-E17CEE9C-5FDA-4651-A039-E132609FDA51Q37442961-81AB28D7-6830-48AF-9129-96EB5BDDE696Q37494959-09EFD238-91C6-44DB-A06E-26D1F64B7CF9Q37611847-1F3A8F80-6CAD-4957-BC68-F7653DF47F23Q38343039-FFC8C3FE-C4E9-4FB4-9632-5DFBB9FCDA10Q41811038-8E9D1AD5-51B3-4AE0-B6F5-B3DC345F943DQ41843114-6332B0DA-D678-4373-ADD6-29EEC5A2D900Q42147342-2E2E2713-E7A7-4E43-9366-2AE8A6CC6EF4Q42909359-BAC3163C-6899-4255-A101-387FF0DBEA55Q43081240-A6B48D9E-45DC-4C29-AAD7-434BA3CB13BFQ43186580-A8556E17-134C-4A0C-9194-FB2B036CDCEBQ44345622-4FA99A94-B06F-4676-BBFB-2D7F1F8B2B0BQ46398936-EFE6C644-2A24-4B33-90D5-01517885820BQ46990464-A6D7C7E4-518B-4D96-9B1C-AEC67CAD2E08Q47146727-0ABE78A9-CA2A-4019-8903-9D0CAFB1D47DQ47809227-A793AF98-F8F1-487B-A12B-2E54B3F23D94Q48048742-CC7123DE-C86A-41A4-A1D0-F489347EAB42Q48254467-5C3C14CC-E03B-4B7E-8113-576E310C96ACQ48664603-DAD4CD13-0A78-4672-B796-F8F8B6B10601Q55257365-B99052D0-1B1A-4833-91BB-9555EB504490Q55425399-898D55EB-C2F6-42CF-9228-323D6D9C2309Q57500278-2A16033E-026B-4E52-89EA-BA1F0CE95905Q58257238-E6B5999E-BC7A-47FC-BB96-82E029E50E15
P2860
Basic and clinical pharmacology of new motility promoting agents.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Basic and clinical pharmacology of new motility promoting agents.
@ast
Basic and clinical pharmacology of new motility promoting agents.
@en
Basic and clinical pharmacology of new motility promoting agents.
@nl
type
label
Basic and clinical pharmacology of new motility promoting agents.
@ast
Basic and clinical pharmacology of new motility promoting agents.
@en
Basic and clinical pharmacology of new motility promoting agents.
@nl
prefLabel
Basic and clinical pharmacology of new motility promoting agents.
@ast
Basic and clinical pharmacology of new motility promoting agents.
@en
Basic and clinical pharmacology of new motility promoting agents.
@nl
P2860
P1476
Basic and clinical pharmacology of new motility promoting agents.
@en
P2093
J J Galligan
P2860
P304
P356
10.1111/J.1365-2982.2005.00675.X
P577
2005-10-01T00:00:00Z